Literature DB >> 8647855

Modulation of the SH2 binding specificity and kinase activity of Src by tyrosine phosphorylation within its SH2 domain.

D R Stover1, P Furet, N B Lydon.   

Abstract

The Src family of kinases are held in an inactive state by interaction of their SH2 domain with a C-terminal phosphotyrosine. Dephosphorylation of this site can reactivate Src; however, recent evidence suggests that activation can also occur without dephosphorylation. In this study, platelet-derived growth factor receptor phosphorylation of Src on Tyr-213 specifically blocked binding of its SH2 domain to a phosphopeptide corresponding to the C-terminal regulatory sequence, while binding to other sequences, such as the platelet-derived growth factor receptor or a peptide from the epidermal growth factor receptor, was unaffected. Consequently, Src was activated over 50-fold. This is the first demonstration of regulation of a SH2 domain specificity by post-translational modification and is likely to be a general mechanism for regulation of all Src-like kinases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647855     DOI: 10.1074/jbc.271.21.12481

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Zinc induces a Src family kinase-mediated up-regulation of NMDA receptor activity and excitotoxicity.

Authors:  P Manzerra; M M Behrens; L M Canzoniero; X Q Wang; V Heidinger; T Ichinose; S P Yu; D W Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  Functional impact of PTP1B-mediated Src regulation on oxidative phosphorylation in rat brain mitochondria.

Authors:  Etienne Hébert Chatelain; Jean-William Dupuy; Thierry Letellier; Jeanne Dachary-Prigent
Journal:  Cell Mol Life Sci       Date:  2010-11-10       Impact factor: 9.261

3.  SRC family kinases and receptors: analysis of three activation mechanisms by dynamic systems modeling.

Authors:  Hendrik Fuss; Werner Dubitzky; C Stephen Downes; Mary Jo Kurth
Journal:  Biophys J       Date:  2007-11-30       Impact factor: 4.033

4.  Phosphorylation of Src by phosphoinositide 3-kinase regulates beta-adrenergic receptor-mediated EGFR transactivation.

Authors:  Lewis J Watson; Kevin M Alexander; Maradumane L Mohan; Amber L Bowman; Supachoke Mangmool; Kunhong Xiao; Sathyamangla V Naga Prasad; Howard A Rockman
Journal:  Cell Signal       Date:  2016-05-08       Impact factor: 4.315

5.  A Phosphosite within the SH2 Domain of Lck Regulates Its Activation by CD45.

Authors:  Adam H Courtney; Jeanine F Amacher; Theresa A Kadlecek; Marianne N Mollenauer; Byron B Au-Yeung; John Kuriyan; Arthur Weiss
Journal:  Mol Cell       Date:  2017-07-20       Impact factor: 17.970

Review 6.  Manipulation of Focal Adhesion Signaling by Pathogenic Microbes.

Authors:  Korinn N Murphy; Amanda J Brinkworth
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

7.  Tyrosine phosphorylation of the Lyn Src homology 2 (SH2) domain modulates its binding affinity and specificity.

Authors:  Lily L Jin; Leanne E Wybenga-Groot; Jiefei Tong; Paul Taylor; Mark D Minden; Suzanne Trudel; C Jane McGlade; Michael F Moran
Journal:  Mol Cell Proteomics       Date:  2015-01-13       Impact factor: 5.911

Review 8.  Src family kinases and paclitaxel sensitivity.

Authors:  Xiao-Feng Le; Robert C Bast
Journal:  Cancer Biol Ther       Date:  2011-08-15       Impact factor: 4.742

9.  Is expression or activation of Src kinase associated with cancer-specific survival in ER-, PR- and HER2-negative breast cancer patients?

Authors:  Beatrix Elsberger; Bingchao A Tan; Thomas J Mitchell; Sylvia B F Brown; Elizabeth A Mallon; Sian M Tovey; Timothy G Cooke; Valerie G Brunton; Joanne Edwards
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

10.  Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets.

Authors:  Martin L Miller; Evan J Molinelli; Jayasree S Nair; Tahir Sheikh; Rita Samy; Xiaohong Jing; Qin He; Anil Korkut; Aimee M Crago; Samuel Singer; Gary K Schwartz; Chris Sander
Journal:  Sci Signal       Date:  2013-09-24       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.